Although HIV can now be effectively suppressed using anti-retroviral drugs, it still comes surging back the moment the flow of drugs is stopped. Latent reservoirs of HIV-infected cells, invisible to the body’s immune system and unreachable by pharmaceuticals, ensure that the infection will rebound after therapy is terminated.

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.

Companies combine expertise to produce cytomegalovirus vaccine candidates.

Since they were first developed a quarter-century ago, carbon nanotubes (CNTs) have impressed scientists with their mechanical strength and stiffness, their optical performance, and their ability to conduct heat and electricity.

Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today (July 16) that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.

Learn about the benefits of UPC2 in the analysis of tricyclic antidepressants in human urine.

This application note shows how UltraPerformance Convergence Chromatography combined with ESI-MS/MS enabled the simultaneous profiling of 25 bile acids within 13 minutes.

Automated solution unlocks the power of clinical data and accelerates LC-MS/MS workflows.

Lawrence Livermore National Laboratory recently received $5.6 million from the Department of Defense's Defense Advanced Research Projects Agency (DARPA) to develop an implantable neural interface with the ability to record and stimulate neurons within the brain for treating neuropsychiatric disorders.

Researchers find a small molecule that predicts treatment response for depressed patients